Os01g0652300 Antibody

What is Os01g0652300 and what format is the antibody typically supplied in?

Os01g0652300 is a rice (Oryza sativa) protein, and antibodies against this target are typically supplied in lyophilized form similar to other plant protein antibodies such as Os10g0167300. For optimal preservation of antibody function:

• Store in a manual defrost freezer to prevent degradation from temperature fluctuations

• Avoid repeated freeze-thaw cycles that can compromise antibody performance

• Upon receipt, store immediately at the recommended temperature (typically -20°C for long-term storage)

• Before reconstitution, the lyophilized antibody can typically be stored at 4°C for short periods

These storage conditions are critical for maintaining antibody quality throughout your research timeline and ensuring reproducible results across experiments.

What cross-reactivity patterns might be expected with Os01g0652300 antibody?

Plant protein antibodies often demonstrate cross-reactivity with homologous proteins across related species. Based on patterns observed with similar rice protein antibodies, Os01g0652300 antibody may cross-react with:

Cross-reactivity is determined by the conservation of epitope sequences across species. Always validate antibody specificity in your species of interest before conducting extensive experiments, particularly when working with species not previously tested .

What are the recommended sample preparation techniques for Os01g0652300 detection?

For optimal detection of plant proteins like Os01g0652300, follow these methodical sample preparation procedures:

• Extract total soluble proteins using a buffer containing:

  • 100 mM Tris-HCl (pH 8.0)

  • 50 mM EDTA (pH 8.0)

  • 100 mM NaCl

  • 1% SDS

  • 1% β-mercaptoethanol

• Tissue disruption protocol:

  • Grind tissue with liquid nitrogen using a mortar and pestle

  • Transfer immediately to extraction buffer to prevent protein degradation

  • Centrifuge at ≥13,000 × g to remove cell debris

• Protein quantification:

  • Use Bradford or BCA assay to standardize protein loading

  • For Western blotting, load 10-30 μg total protein per lane

  • For immunoprecipitation, start with 200-500 μg total protein

This approach ensures efficient extraction while preserving protein integrity, which is essential for accurate detection and quantification of Os01g0652300 in plant samples.

What are the optimal Western blotting conditions for Os01g0652300 detection?

For reliable Western blot detection of Os01g0652300, follow these optimized conditions:

• Sample preparation:

  • Extract proteins using the buffer described in section 1.3

  • Heat samples in Laemmli buffer at 95°C for 5 minutes before loading

  • Include fresh protease inhibitors in all buffers

• Gel electrophoresis parameters:

  Parameter	Recommendation	Rationale
  Gel percentage	10-12%	Optimal separation for mid-sized proteins
  Running buffer	1X Tris-Glycine-SDS	Standard for protein separation
  Voltage	100-120V	Prevents band distortion
  Run time	Until tracking dye reaches bottom	Ensures complete separation

• Transfer conditions:

  • Use PVDF membrane for optimal protein retention

  • Transfer at 100V for 1 hour in cold transfer buffer or 30V overnight at 4°C

  • Verify transfer with reversible Ponceau S staining

• Immunodetection protocol:

  • Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Incubate with primary antibody (1:1000-1:2000 dilution) overnight at 4°C

  • Wash 3× with TBST, 10 minutes each

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:2000-1:5000) for 1 hour

  • Wash 3× with TBST, 10 minutes each

  • Detect using ECL system appropriate for expected protein abundance

These conditions should provide specific detection with minimal background, allowing for accurate visualization of Os01g0652300 in plant samples.

How can ELISA be optimized for quantitative measurement of Os01g0652300?

ELISA provides highly sensitive quantitative measurement of Os01g0652300 levels. For optimal results:

• Plate coating:

  • Use high-binding 96-well plates

  • Coat with capture antibody (1-5 μg/ml) in carbonate buffer (pH 9.6)

  • Incubate overnight at 4°C or 2 hours at room temperature

• Sample preparation:

  • Extract proteins in a non-denaturing buffer to preserve native epitopes

  • Prepare a standard curve using recombinant protein if available

  • Include technical triplicates for each biological sample

• Assay protocol:

  • Block with 1-3% BSA in PBST for 1-2 hours

  • Add samples and standards, incubate for 2 hours at room temperature

  • Wash 5× with PBST

  • Add detection antibody (typically 0.5-2 μg/ml)

  • Develop with appropriate substrate and measure absorbance

• Data analysis:

  • Generate standard curve using 4-parameter logistic regression

  • Normalize to total protein concentration if comparing across samples

  • Calculate coefficient of variation (CV) to assess technical precision (aim for <15%)

The sensitivity of ELISA makes it particularly valuable for detecting low-abundance proteins or subtle changes in expression levels across experimental conditions .

How can Os01g0652300 antibody be validated for specificity in immunological experiments?

Thorough validation of antibody specificity is essential for reliable research outcomes:

• Western blot analysis:

  • Include positive controls (tissues known to express Os01g0652300)

  • Include negative controls (knockout/knockdown lines if available)

  • Check for single bands at the expected molecular weight

  • Compare with RT-PCR data to correlate protein with mRNA expression

• Peptide competition assay:

  • Pre-incubate antibody with excess immunizing peptide

  • Run parallel Western blots with blocked and unblocked antibody

  • Specific bands should disappear in the blocked antibody lane

• RT-PCR correlation:

  • Extract RNA using TRIzol or similar reagent

  • Perform DNase I treatment to eliminate DNA contamination

  • Synthesize cDNA using oligo-dT primers and reverse transcriptase

  • Amplify with gene-specific primers (typically 26-28 cycles with denaturation at 95°C for 20s, annealing at 50°C for 45s, and extension at 72°C for 1 min)

  • Compare protein detection patterns with mRNA expression profiles

These validation steps ensure that experimental observations reflect genuine Os01g0652300 biology rather than artifacts from non-specific binding.

What protocols are recommended for co-immunoprecipitation experiments using Os01g0652300 antibody?

For investigating protein-protein interactions involving Os01g0652300, follow this co-immunoprecipitation protocol:

• Sample preparation:

  • Harvest fresh plant tissue and homogenize in non-denaturing lysis buffer

  • Use a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, and protease inhibitor cocktail

  • Centrifuge at 14,000 × g for 15 minutes at 4°C to remove debris

• Pre-clearing and antibody binding:

  • Incubate lysate with protein A/G beads for 1 hour at 4°C to reduce non-specific binding

  • Remove beads by centrifugation

  • Add Os01g0652300 antibody (2-5 μg per mg of total protein)

  • Incubate overnight at 4°C with gentle rotation

  • Add fresh protein A/G beads and incubate for 2-3 hours at 4°C

• Washing and elution:

  • Wash beads 4-5 times with wash buffer (lysis buffer with reduced detergent)

  • Elute bound proteins with SDS sample buffer or low pH glycine buffer

  • Analyze by SDS-PAGE followed by Western blotting for Os01g0652300 and potential interacting partners

• Essential controls:

  • IgG control (same species as the primary antibody)

  • Input sample (5-10% of starting material)

  • Sequential detection with antibodies against suspected interaction partners

This protocol can help identify protein complexes involving Os01g0652300, providing insights into its functional networks in plant cells.

How do post-translational modifications of Os01g0652300 affect antibody binding?

Post-translational modifications (PTMs) can significantly impact antibody recognition and experimental results:

• Potential PTMs affecting antibody binding:

  Modification	Potential Impact on Antibody Binding
  Phosphorylation	May alter epitope conformation or accessibility
  Glycosylation	Can physically block antibody access to protein epitopes
  Ubiquitination	May create multiple bands or affect antibody recognition
  Proteolytic processing	May remove epitope regions entirely

• Analysis strategies for PTM assessment:

  • Treatment with phosphatase to identify phosphorylation effects

  • Use of glycosidases to assess glycosylation impacts

  • Inclusion of specific protease inhibitors in extraction buffers

  • Comparison of samples from different tissues/conditions to identify modification patterns

• Detection methods for PTMs:

  • 2D gel electrophoresis to separate protein isoforms

  • Specific PTM antibodies in parallel experiments

  • Mass spectrometry analysis for comprehensive PTM mapping

Understanding these modification patterns is critical for correctly interpreting experimental results, particularly when comparing Os01g0652300 expression or interactions across different experimental conditions .

How can Os01g0652300 antibody be used to investigate protein expression during plant development?

Tracking Os01g0652300 expression throughout development requires systematic experimental design:

• Sampling strategy:

  Developmental Stage	Tissues to Sample	Special Considerations
  Seed/germination	Whole seedling	Higher extraction buffer:tissue ratio
  Vegetative growth	Leaves, roots, stems	Compare across tissue types
  Reproductive stage	Flowers, developing seeds	Tissue-specific extraction protocols
  Senescence	Aging leaves	Extra protease inhibitors needed

• Quantitative analysis approaches:

  • Western blotting with internal standards for semi-quantitative analysis

  • ELISA for precise quantification as described in methods like those used for recombinant proteins

  • Normalization to consistently expressed housekeeping proteins

• Experimental design:

  • Time-course sampling at regular intervals

  • Multiple biological replicates to account for plant-to-plant variation

  • Correlation with transcript levels using RT-PCR

  • Use of standardized growth conditions to minimize environmental variables

This systematic approach allows researchers to build a comprehensive profile of Os01g0652300 expression throughout plant development, providing insights into its developmental regulation and function.

How can non-specific binding be reduced when using Os01g0652300 antibody?

Non-specific binding is a common challenge in plant protein immunodetection. Implement these strategies to improve specificity:

• Blocking optimization:

  Blocking Agent	Concentration	Advantages	Considerations
  Non-fat dry milk	3-5%	Economical, effective	Contains biotin and phosphoproteins
  BSA	1-5%	Good for phospho-specific antibodies	More expensive than milk
  Casein	1-2%	Alternative with lower background	May need optimization

• Washing optimization:

  • Increase number of washes (5-6 washes of 5-10 minutes each)

  • Add 0.1-0.3% Tween-20 to wash buffer to reduce hydrophobic interactions

  • Consider using TBS instead of PBS if phospho-proteins are being detected

• Antibody incubation modifications:

  • Perform antibody titration experiments to determine optimal concentration

  • Incubate primary antibody at 4°C overnight rather than at room temperature

  • Add 0.1% Tween-20 and 1% BSA to antibody dilution buffer

• Additional strategies:

  • Pre-absorb antibody with plant extract from unrelated species

  • Use high-quality, freshly prepared reagents

  • Apply design of experiment (DOE) approaches to systematically optimize conditions

These strategies can significantly improve signal-to-noise ratio when working with plant antibodies like Os01g0652300 in complex tissue samples.

What are common causes of false negatives when using Os01g0652300 antibody?

False negatives can occur for various reasons. Identify and address these common causes:

• Protein extraction issues:

  • Insufficient extraction due to inappropriate buffer composition

  • Protein degradation during sample preparation

  • Inefficient tissue disruption limiting protein release

  • Solution: Optimize extraction buffer composition and include appropriate protease inhibitors

• Epitope accessibility problems:

  • Protein denaturation affecting epitope structure

  • Epitope masking by interacting proteins or modifications

  • Epitope location in membrane-embedded regions

  • Solution: Try multiple extraction conditions (native vs. denaturing) and consider epitope retrieval methods

• Technical issues:

  • Insufficient primary or secondary antibody concentration

  • Inefficient protein transfer to membrane

  • Antibody deterioration due to improper storage

  • Solution: Verify transfer efficiency with Ponceau S staining and optimize antibody concentrations

• Biological factors:

  • Low expression levels requiring enhanced detection methods

  • Developmental or tissue-specific expression patterns

  • Environmental conditions affecting protein expression

  • Solution: Use signal enhancement systems like ECL prime and ensure appropriate positive controls

Addressing these factors systematically can help resolve false negative results and improve detection reliability.

How can antibody concentration be optimized for detection of low-abundance Os01g0652300?

Detecting low-abundance proteins requires careful optimization:

• Antibody concentration optimization:

  • Start with manufacturer's recommended dilution

  • Test a range of concentrations in 2-fold or 3-fold dilution series

  • Record signal-to-noise ratio at each concentration

  • Select the concentration that provides optimal signal with minimal background

• Sample enrichment strategies:

  • Immunoprecipitation before Western blotting to concentrate target protein

  • Subcellular fractionation to isolate compartments containing Os01g0652300

  • Use larger amounts of starting material when possible

• Enhanced detection systems:

  Detection System	Sensitivity	Best Application Scenario
  Standard ECL	+	High abundance proteins
  ECL Prime	+++	Low to moderate abundance proteins
  Fluorescent secondary antibodies	++	Quantitative analysis, multiplexing
  Biotin-streptavidin amplification	++++	Very low abundance proteins

• Signal enhancement approaches:

  • Extended primary antibody incubation (overnight at 4°C)

  • Use of signal enhancers in detection reagents

  • Extended exposure times for chemiluminescence detection

  • Signal accumulation using CCD camera with multiple exposures

These optimization strategies can significantly improve detection sensitivity while maintaining specificity, allowing successful detection of even low-abundance Os01g0652300 protein .

What considerations should be made for detecting Os01g0652300 under different stress conditions?

Stress conditions can significantly alter protein expression and characteristics, requiring special considerations:

• Expression level changes:

  • Stress may induce up- or down-regulation of Os01g0652300

  • Adjust loading amounts or exposure times accordingly

  • Include housekeeping proteins (like actin) that remain stable under stress conditions

• Extraction modifications:

  • Different buffer compositions may be needed for stressed vs. control samples

  • Include additional protease inhibitors as stress often activates proteases

  • Consider osmolyte addition for samples from osmotic stress experiments

• Experimental design recommendations:

  Stress Type	Special Considerations
  Drought	Include compatible solutes in extraction buffer
  Salt	Use desalting steps before electrophoresis
  Heat	Rapid sample collection and processing
  Cold	Maintain samples cold throughout extraction
  Pathogen	Consider timing relative to infection progression

• Control considerations:

  • Always run control and stressed samples on the same gel

  • Include time-course samples to track dynamic changes

  • Use quantitative approaches like ELISA for precise measurements of abundance changes

These considerations help ensure accurate detection and interpretation of Os01g0652300 behavior under stress conditions, which is particularly important for functional studies of stress-responsive proteins in plants.

How can Os01g0652300 antibody be effectively used in multiplex immunoassays?

Multiplex approaches allow simultaneous detection of multiple proteins, saving time and sample material:

• Antibody selection criteria:

  • Choose antibodies raised in different host species (e.g., rabbit, mouse, goat)

  • For antibodies from the same species, use directly labeled primary antibodies

  • Verify that target proteins have sufficiently different molecular weights

• Fluorescence-based multiplex Western blotting:

  • Use secondary antibodies with distinct fluorophores (e.g., Cy3 and Cy5)

  • Include appropriate filter sets during imaging to prevent bleed-through

  • Use digital imaging systems for quantitative analysis

• Sequential detection protocol:

  • Probe first with Os01g0652300 antibody and detect

  • Strip membrane with appropriate stripping buffer

  • Verify complete stripping by re-exposure

  • Re-block membrane and probe with second antibody

• Multiplex co-immunoprecipitation strategies:

  • Perform co-IP with Os01g0652300 antibody

  • Analyze precipitated proteins by Western blot with antibodies against suspected interaction partners

  • Use reciprocal IPs to confirm interactions

This approach can reveal relationships between Os01g0652300 and other proteins, providing insights into functional networks and regulatory mechanisms .

How can CRISPR technology complement Os01g0652300 antibody research?

CRISPR/Cas9 technology can enhance antibody-based studies of Os01g0652300:

• Generation of validation resources:

  • Create knockout/knockdown lines for negative controls

  • Develop epitope-tagged Os01g0652300 for antibody validation

  • Engineer lines with altered Os01g0652300 regulation for functional studies

• CRISPR knock-in applications:

  • Insert reporter tags (GFP, FLAG, etc.) for enhanced detection

  • Create models with specific mutations to study structure-function relationships

  • Implement intron-targeting insertion techniques for minimal disruption of gene function

• Complementary analytical approaches:

  • Compare antibody detection in wild-type vs. CRISPR-modified plants

  • Use antibody-based methods to validate CRISPR-induced changes

  • Combine CRISPR modification with stress or developmental studies

• Experimental design considerations:

  • Generate homozygous and heterozygous modification lines

  • Verify genetic stability across generations

  • Confirm phenotypic stability in different environmental conditions

This integration of CRISPR technology with antibody-based detection provides powerful tools for comprehensive analysis of Os01g0652300 function in plant biology .